Close

Analyst Ratings for Marker Therapeutics (MRKR) [Buys]

MRKR Rating Summary

  |   Expand Research on MRKR
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8.6 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2021 Piper Sandler
» Updated 5/31/2022
Joseph Catanzaro New Coverage Overweight
(N/A)
1.50
(3.50)
2.58
(4.43)
71.71% Details
3/19/2021 Cantor Fitzgerald Kristen Kluska New Coverage Overweight
(N/A)
6.00
(N/A)
1.88
(4.43)
135.64% Details